Cart
sales@molnova.com
ONO-8713
CAS No. 459411-08-6
ONO-8713( —— )
Catalog No. M35732 CAS No. 459411-08-6
ONO-8713 is a selective prostaglandin E receptor subtype EP1 antagonist used to study diseases of the biblical system and metabolism-related diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 603 | Get Quote |
|
| 5MG | 922 | Get Quote |
|
| 10MG | 1121 | Get Quote |
|
| 25MG | 1454 | Get Quote |
|
| 50MG | 1822 | Get Quote |
|
| 100MG | 2250 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameONO-8713
-
NoteResearch use only, not for human use.
-
Brief DescriptionONO-8713 is a selective prostaglandin E receptor subtype EP1 antagonist used to study diseases of the biblical system and metabolism-related diseases.
-
DescriptionONO-8713 is a selective prostaglandin E receptor subtype EP1 antagonist.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetProstaglandin Receptor
-
RecptorProstaglandin Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number459411-08-6
-
Formula Weight523.52
-
Molecular FormulaC25H24F3NO6S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN(S(=O)(=O)C1=CC=CO1)(CC(C)C)C2=C(OCC3=CC=C(C=CC(O)=O)C=C3)C=C(C(F)(F)F)C=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Watanabe K, et al. Inhibitory effect of a prostaglandin E receptor subtype EP(1) selective antagonist, ONO-8713, on development of azoxymethane-induced aberrant crypt foci in mice. Cancer Lett. 2000 Aug 1;156(1):57-61. ?
molnova catalog
related products
-
Evatanepag
Evatanepag is an EP2 receptor selective prostaglandin E2 (PGE2) agonist that induces local bone formation with EC50 of 0.3 nM.
-
Bimatoprost
Bimatoprost is a prostaglandin analog used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension.
-
Omidenepag Isopropyl
Omidenepag Isopropyl (DE-117, OMDI) is the prodrug of Omidenepag, which is a potent, selective agonist human EP2 receptor.
